Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

616

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2007

Conditions
Total Hip and Knee Arthroplasties
Interventions
DRUG

Teicoplanin

The selected dose was 10mg/kg and it was given intravenously by a catheter inserted under aseptic conditions in a forearm vein within 15 minutes; it was diluted in one 5% glucose solution of a 50 ml final volume

DRUG

β-lactams or ciprofloxacin

Multiple doses for up to six consecutive days

Trial Locations (3)

14527

2nd Department of Orthopedics, KAT Hospital, Marousi

3rd Department of Orthopedics, KAT Hospital, Marousi

4th Department of Orthopedics, KAT Hospital, Marousi

All Listed Sponsors
collaborator

KAT Hospital of Athens

UNKNOWN

lead

University of Athens

OTHER

NCT00719056 - Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty | Biotech Hunter | Biotech Hunter